Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.
about
The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphismssuPAR as a prognostic biomarker in sepsisSoluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblastsUtility of the plasma level of suPAR in monitoring risk of mortality during TB treatmentSoluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.Urokinase and its receptors in chronic kidney disease.Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort studyRole of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections
P2860
Q21261761-5EF8D5B2-7AA0-4A1B-A14D-050FCF0E53EBQ26858996-491D4793-EC52-41A6-AB4F-F9C0416723EEQ27690715-0B0A5906-C5A1-49D6-88D7-2CE5D44625C5Q33556249-A858024B-B921-44CA-8FEF-538B2A0E2432Q34399577-C2574C71-D4CE-4712-B641-12BB1428D194Q35100841-F9973B87-767B-4BE6-BDF9-900B00738534Q35124141-51B3E330-C5E5-42E5-9623-5371DE82B252Q36496226-9D65617A-5418-4339-A802-4DF3C4F78F4AQ37004095-DD038B68-6AC6-451D-A32F-1F98D43C6ED3
P2860
Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Plasma levels of soluble uroki ...... ral treatment in South Africa.
@ast
Plasma levels of soluble uroki ...... ral treatment in South Africa.
@en
Plasma levels of soluble urokinase-type plasminogen activator receptor
@nl
type
label
Plasma levels of soluble uroki ...... ral treatment in South Africa.
@ast
Plasma levels of soluble uroki ...... ral treatment in South Africa.
@en
Plasma levels of soluble urokinase-type plasminogen activator receptor
@nl
prefLabel
Plasma levels of soluble uroki ...... ral treatment in South Africa.
@ast
Plasma levels of soluble uroki ...... ral treatment in South Africa.
@en
Plasma levels of soluble urokinase-type plasminogen activator receptor
@nl
P2860
P50
P356
P1476
Plasma levels of soluble uroki ...... ral treatment in South Africa.
@en
P2093
Monica Vogt
Nonzwakazi Bangani
P2860
P2888
P356
10.1186/1471-2334-7-41
P577
2007-05-17T00:00:00Z
P5875
P6179
1029337682